PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

A compound having the structure of Formula (Ibb):

• or a pharmaceutically acceptable salt thereof, wherein:
• R1 is hydrogen, halogen, —C1-C4-alkyl, —C1-C4-haloalkyl, —CN, —C1-C4-alkoxy, —C1-C4-haloalkoxy, or —C3-C6-cycloalkyl;
• R2 is hydrogen, halogen, —CN, —C1-C4-alkyl, —C1-C4-haloalkyl, —C3-C6-cycloalkyl, —C1-C4-alkoxy, —C1-C4-haloalkoxy, —S(C1-C4-alkyl), —SO2(C1-C4-alkyl), 5- or 6-membered heterocyclyl, aryl, 5-membered heteroaryl, —≡—R2A, —O(CH2)mR2B, —NH(C1-C4-alkyl), —N(C1-C4-alkyl)2, or —C(O)(C1-C4-alkyl), wherein aryl and heteroaryl are optionally substituted with halogen, —OH, —CN, C1-C4-alkyl, formyl, acetyl, acetoxy, or carboxy, and wherein m is an integer having value of 1, 2, or 3;
• R2A and R2B are each independently —C1-C4-alkyl, —C1-C4-haloalkyl, or —C3-C6-cycloalkyl;
• each R20 is independently hydrogen, halogen, —C1-C4-alkyl, —CN, or —C1-C4-alkoxy;
• and
• x is an integer having a value of 1 or 2.